| Literature DB >> 31425909 |
Yangqing Su1, Lingkuan Meng1, Jiaqi Sun2, Weijia Li1, Liang Shao1, Kexuan Chen1, Demin Zhou2, Fan Yang3, Fei Yu4.
Abstract
The development of entry inhibitors is an emerging approach to the inhibition of influenza virus. In our previous research, oleanolic acid (OA) was discovered as a mild influenza hemagglutinin (HA) inhibitor. Herein, as a further study, we report the preparation of a series of OA-saccharide conjugates via the CuAAC reaction, and the anti-influenza activity of these compounds was evaluated in vitro. Among them, compound 11b, an OA-glucose conjugate, showed a significantly increased anti-influenza activity with an IC50 of 5.47 μM, and no obvious cytotoxic effect on MDCK cells was observed at 100 μM. Hemagglutination inhibition assay and docking experiment indicated that 11b might interfere with influenza virus infection by acting on HA protein. Broad-spectrum anti-influenza experiments showed 11b to be robustly potent against 5 different strains, including influenza A and B viruses, with IC50 values at the low-micromole level. Overall, this finding further extends the utility of OA-saccharide conjugates in anti-influenza virus drug design.Entities:
Keywords: Entry inhibitor; Hemagglutinin; Influenza virus; Oleanolic acid
Mesh:
Substances:
Year: 2019 PMID: 31425909 DOI: 10.1016/j.ejmech.2019.111622
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514